In recent years, the pace of parasite resistance against the safest and least expensive antimalarials has been accelerating. A new approach to combat malaria is combination therapy. Artemether + lumefantrine is the first fixed-dose antimalarial combination containing an artemisinin derivative and is included in the kit for the treatment of malaria due to Plasmodium falciparum, including Plasmodium falciparum in areas with significant drug resistance. It is not recommended for prophylaxis and should not be used by women in the first trimester of their pregnancy, since safety in pregnancy has not yet been established. Rapid diagnostic tests (RDTs) are included in the malaria modules for the confirmation of suspected malaria cases.
IEHK 2006 will always be supplied with malaria modules unless there is a specific request not to include these items at the time of ordering.